SQA

FEBRUARY 26, 2024

The products had been improperly regularized in ANVISA as cosmetics since they are indicated for injectable use, a form that is not authorized for this category of product. The purpose of the note is to clarify that products for invasive aesthetic treatments cannot be regularized in the category of cosmetics.

FDA 52

FDA Compliance COVID-19 Public Health 52

SQA

DECEMBER 16, 2022

The 20-page Q&A document covers general and specific topics including the importation of cannabis products, simplified authorization procedures for education, and research institutions that are conducting cannabis studies using real-life data. It will promote pooling resources and achieving economies of scale. CMDE Announcement No.

FDA 40

FDA Compliance COVID-19 Licensing 40

HIT Consultant

MARCH 15, 2022

This strategic combination will help meet increased market demand for more advanced interoperability solutions that address data quality as well as data-sharing, furthering Lyniate’s commitment to building connections for a healthier world. Strategic Partnerships. MEDITECH and Google Health Partner on Integrated Solution.

Hospitals 97

Hospitals FDA Health Outcomes Doctors 97

AIHC

JUNE 14, 2023

AI is advancing rapidly, so we encourage you to reference the new Artificial Intelligence article category for the latest articles. Recently NIST launched the Trustworthy and Responsible AI Resource Center (AIRC), which will facilitate implementation of, and international alignment with, the AI RMF.

FDA 45

FDA HIPAA Compliance Regulatory Compliance 45

Healthcare IT Today

MAY 2, 2023

As a result, health equity has been a hot topic and organizations have been searching for solutions. from both public and private sources) and the formats in which they are available, then co-relate points between the data sets to ascertain the entities, attributes, risk category domains, and measures across which analysis needs to be done.

Health Outcomes 101

Health Outcomes Governance Nurses Hospitals 101